PPARγ activation is positively related to ameliorating experimental autoimmune encephalomyelitis (EAE) in mice [28] and reducing amyloid deposition along with improving cognitive function in Alzheimer’s disease models [29]. This evidence concerns the gene PPARG and early-onset autosomal dominant Alzheimer disease.